Participants with recurrent bacterial vaginosis demonstrated a significantly higher treatment response to oral metronidazole than to intravaginal lactic acid gel at 2 weeks, but treatment failure was ...

BRIDGEWATER, N.J.--(BUSINESS WIRE)--Cosette Pharmaceuticals, Inc. ("Cosette") announced that the U.S. Food and Drug Administration (FDA) has approved the Abbreviated New Drug Applications (ANDA) for ...

Actavis and Valeant announced that the FDA has approved Metronidazole 1.3% Vaginal Gel for the treatment of bacterial vaginosis. In April 2013, Actavis acquired the rights to Metronidazole 1.3% from ...

The Food and Drug Administration recently approved Glenmark ’s Metronidazole Vaginal gel 0.75%. [Read more: Glenmark obtains FDA nod for generic Brovana] The medication is the generic of Bausch Health ...

CINCINNATI--(BUSINESS WIRE)--Prasco Laboratories, a Cincinnati-based pharmaceutical company, announced today it has entered into a distribution and supply agreement with Graceway Pharmaceuticals, LLC.

CHICAGO – Application of a new formulation of azelaic acid gel to the face reduces the redness and lesions associated with rosacea better than a commonly used treatment (metronidazole gel), according ...

Metronidazole 0.75%; vaginal gel; contains parabens. Discontinue if abnormal neurological signs develop. CNS or hepatic disease. Abstain from vaginal intercourse during therapy. Pregnancy (Cat.B).

HAWTHORNE, N.Y., July 18, 2006 (PRIMEZONE) -- Taro Pharmaceutical Industries Ltd. (Nasdaq:TARO) reported today that it has received approval from the U.S. Food and Drug Administration for its ...

Alembic Pharmaceuticals’ joint venture, Aleor Dermaceuticals, has received approval from the Food and Drug Administration for its generic Metrogel Gel (metronidazole gel, 1%). The topical gel is ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Actavis and Valeant Pharmaceuticals International Inc.

Of all risk factors explored thus far, the majority of epidemiologic studies have identified sexual behaviour as the primary risk factor to the occurrence of BV. The nature of this association remains ...

Background: Women with cervicitis frequently have bacterial vaginosis (BV). Prior studies have suggested that BV is involved in the pathogenesis of cervicitis. Goals: To delineate the association of ...